Noticias
|
|
 |
 |
|
|
|
Des messages ont été addresses du monde entier.
Plus d’une centaine d’entre vous ont assisté à la célébration religieuse en l’église de Villejuif, puis à la cérémonie d’hommage organisée à l’IGR le 24 octubre 2016.
Madame Marie-Elisabeth Chassagne son épouse, Emmanuel, Vincent, Amélie, Thomas ses enfants, très touchés par votre sollicitude, vos marques d’affection, d’amitié, vous adressent leurs plus sincères remerciements. |
 |
|
Fue residente al Memorial Hospital (Cornell University) de New-York (EEUU) en 1959-60,de 1964 a 1993 fue profesor de radioterapia a la Université Paris XI y fue director del Departamento de Radioterapia del Institut Gustave Roussy de 1981 a 1989, Fue miembro de muchos organismos nacionales e internacionales. En particular, fue Presidente de la European Society of Therapeutic Radiology and Oncology (ESTRO) en 1988-89 y Co-fundador (1964) del Groupe Européen de Curiethérapie (GEC ahora GEC-ESTRO), Fue autor de muchos trabajos innovadores en el campo de la braquiterapia, en particular: Traité de curiethérapie (1964), Modern Brachytherapy (1987). |
 |
Recibió la Medalla conmemorativa de África del Norte y muchos premios: premio de la Fundación Fernandino Palasciano (Italia, 1984), Memorial Henschke Lecture (1988), Fellow (miembro honorario) del Royal College of Radiology (Gran Bretana1990), Fellow (miembro honorario) del American College of Radiology (EEUU, 1991), Medalla de Plata de la Crux Roja francesa, Medalla de Iridio del GEC-ESTRO (2007), como Miembro Fundador de ESTRO (2011).
Siempre fue un hombre simple y reservado, que amaba las cosas simples de la vida, como cuidar su jardín y nadar.
|
EORTC wants here by to acknowledge his contribution to the treatment of so many patients around the world who benefited from his work . His visionary approach to cancer treatment and his commitment to cancer clinical research notably has greatly served advances in the field of methodology. Under his leadership, EORTC was able to initiate the upgrade of the clinical research infrastructure based at the EORTC Data Center and launch the first consensus conference on quality control procedures. On the foreword of the 1988-1989 EORTC report, Professor Umberto Veronesi was already addressing the issue of cost/benefit relationship in our work, exemplifying his early vision of modern challenges. |
 |
One of the leading oncology experts, Prof Veronesi revolutionized breast cancer surgery procedure with the introduction of an innovative breast-conserving technique (quadrantectomy) and the development of sentinel node biopsy to avoid complete axilliary dissection.
Prof Veronesi served as president of several cancer organisations and as Italian Minister for Health from 2000 – 2001, where he contributed to the introduction of cancer prevention policies. He also chaired the WHO melanoma group for 20 years.
Professor Veronesi has been awarded 14 honorary medical degrees from universities throughout the world and has been recognized for his breakthrough work with many distinctions, including a Nobel prize nomination; the Italian Ministry of Health Gold Medal; the American Cancer Society National Award for his work on the treatment of breast cancer; the German Johann Georg Zimmermann Award and ECCO Lifetime Achievement Award.
Professor Veronesi has inspired many advances in the field of oncology and has been a champion and model for clinicians and researchers. His contribution to the field changed the life of patients with cancer and we are deeply grateful for the role he has played as EORTC President.
ICARO2 - Abstract submission deadline extended till 30th November, 2016
We are excited by the substantial number of good quality submissions that have been received so far. Thanks to those who have already submitted your synopses.
Nevertheless, in order to maximise the opportunity to share the latest developments across the range of topics represented at the ICARO2, we are pleased to extend the deadline for abstract submission to Wednesday 30 November, 2016.
Do not miss this opportunity! Send your proposal by visiting our INDICO Submission website now!
We are looking forward to welcome you to the ICARO2 in June 2017.
The ICARO2 Team
La Asociación Ibero Latinoamericana de Radioterapia Oncológica (ALATRO) cumple con el penoso deber de informar el sensible fallecimiento de nuestro amigo y compañero profesional DR. MARCO MEJÍA RODRÍGUEZ, Medico Radio Oncólogo de Panamá, con una impecable y valiosa vida profesional en la Radioterapia Latinoamericana y miembro activo de nuestra Sociedad.
Expresamos nuestras más sentidas condolencias a todos sus familiares y amigos.
Paz a su alma
- |
- Hazte Miembro
- |
- Recuperar Datos
- |
- Aviso Legal
- |
- Mapa Web
- |
- © ALATRO - Asociación Ibero Latinoamericana de Terapia Radiante Oncológica -
- Powered by Aran Ediciones